• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Intelerad Acquires Clinical Workflow Automation Provider HeartIT

by Fred Pennic 07/08/2021 Leave a Comment

Intelerad Acquires Clinical Workflow Automation Provider HeartIT

What You Should Know:

– Intelerad, a global leader in medical image management solutions, announced its acquisition of Heart Imaging Technologies, the leader in clinical workflow automation.

Founded in 2000, Heart Imaging Technologies was the first company to offer an FDA-cleared zero footprint medical image workstation, which has become the precedent for other companies seeking FDA clearance. HeartIT provides web-based medical image management technology and services to health care systems, large hospitals, and private clinics as well as drug and device companies sponsoring multi-center clinical trials. Worldwide, HeartIT solutions provide secure web browser access to over one billion medical images.

– The acquisition falls on the heels of Intelerad’s February acquisition of information systems (CVIS) provider LUMEDX, and marks the company’s fourth acquisition within the past year.

Acquisition Impact

Recent reports value the global medical imaging market at $39 billion in 2020, with North America holding the majority share. With technological advances, rising disease burden and a growing elderly population, imaging and tech integration needs are expected to increase sharply – accelerating growth of the market to over $55 billion by 2026. By integrating HeartIT into the Intelerad family, Intelerad will significantly expand its ability to provide enterprise imaging and insights – advancing its market leadership while also increasing its cardiovascular expertise, customer resources and ROI for customers. 

“The challenges healthcare providers were facing prior to the pandemic are now even more critical, and technology is key to overcoming them,” said Mike Lipps, Intelerad President & Chief Executive Officer. “Our goal at Intelerad is to improve efficiency, productivity, and the user experience for providers. By partnering with HeartIT, we’re enabling our customers to tap into advanced visualization and reporting capabilities while increasing ROI and improving patient outcomes.”

Tagged With: Healthcare Mergers & Acquisitions

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |